We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RZLT market cap is 362.6M. The company's latest EPS is USD -0.8005 and P/E is -5.30.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.21M | -23.1M | -16.94M | -17.08M | -20.02M |
| Net Income | -17.05M | -22.98M | -15.38M | -15.73M | -18.91M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.52M | -22.89M | -41.84M | -55.99M | -70.42M |
| Net Income | -20.33M | -20.9M | -41.06M | -51.79M | -68.46M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 87.74M | 132.74M | 123.41M | 112.01M | 94.74M |
| Total Liabilities | 16.88M | 11.73M | 9.97M | 12.42M | 12.17M |
| Total Equity | 70.86M | 121M | 113.44M | 99.59M | 82.57M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.97M | 42.61M | 152.42M | 123.72M | 132.74M |
| Total Liabilities | 3.6M | 16.51M | 2.95M | 7.55M | 11.73M |
| Total Equity | 7.37M | 26.1M | 149.47M | 116.17M | 121M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -38.85M | -57.37M | -16.01M | -29.68M | -47.08M |
| Investing | 29.04M | 48.7M | -49.41M | -37.94M | -14.89M |
| Financing | -296k | 63.03M | 5.5M | 6.16M | 6.17M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -24.17M | -20.44M | -39.62M | -44.48M | -57.37M |
| Investing | N/A | N/A | N/A | -101.46M | 48.7M |
| Financing | 22.55M | 51.53M | 148.98M | 11.57M | 63.03M |
| Market Cap | 362.6M |
| Price to Earnings Ratio | -5.30 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.15 |
| Price to Book Ratio | 3 |
| Dividend Yield | - |
| Shares Outstanding | 85.52M |
| Average Volume (1 week) | 1.04M |
| Average Volume (1 Month) | 806.91k |
| 52 Week Change | -0.24% |
| 52 Week High | 6.1856 |
| 52 Week Low | 2.215 |
| Spread (Intraday) | 0.11 (2.6%) |
| Company Name | Rezolute Inc |
| Address |
187 e warm springs road las vegas, nevada 89119 |
| Website | https://www.rezolutebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
